Estrogen receptor mRNA variants: Do they have a physiological role?

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 304-313

  Pfeffer, Ulrich ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; RNA DERIVATIVE;

ALTERNATIVE RNA SPLICING; BREAST TUMOR; CONFERENCE PAPER; EXON; GENE DELETION; HUMAN; HUMAN CELL; PHYSIOLOGY;

EID: 0029974755     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16245.x     Document Type: Article

References (38)

1. EVANS, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
2. BEATO, M. 1988. Gene regulation by steroid hormones. Cell 56: 335-344.
3. PARKER, M. G. 1993. Steroid and related receptors. Curr. Opin. Cell Biol. 5: 499-504.
4. TSAI, M-J. & B. W. O'MALLEY. 1994. Molecular mechanisms of action of steroid/ thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-486.
5. KING, R. J. B. 1991. A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J. Steroid Biochem. Mol. Biol. 39: 811-818.
6. LOVE, R. R. 1989. Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. J. Clin. Oncol. 7: 803-815.
7. CLARKE, R. & M. E. LIPPMAN. 1992. Antiestrogen resistance: mechanism and reversal. In Drug Resistance in Oncology. B. A. Teicher, Ed.: 501-536. Dekker. New York.
8. CLARKE, R., E. W. THOMPSON, F. LEONESSA, J. LIPPMAN, M. MCGARVEY, T. L. FRANDSEN & N. BRÜNNER. 1993. Hormone resistance, invasiveness, and metastatic potential in breast cancer. Breast Cancer Res. Treat. 24: 227-239.
9. SAVOURET, J-F., M. RAUCH, G. REDEUILH, S. SAR, A. CHAUCHEREAU, K. WOODRUFF, M. G. PARKER & E. MILGROM. 1994. Interplay between estrogens, progestins, retinoic acid, and AP-1 on a single regulatory site in the progesterone receptor gene. J. Biol. Chem. 269: 28955-28962.
10. HOLLENBERG, S. M., V. GIGUÈRE, P. SEGUI & R. M. EVANS. 1987. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49: 39-46.
11. MCPHAUL, M. J. 1993. Mutations in steroid hormone receptors causing clinical disease. In Steroid Hormone Action. M. G. Parker, Ed.: 186-208. Oxford University Press. London/New York.
12. GREEN, S., P. WALTER, V. KUMAR, A. KRUST, J-M. BORNERT, P. ARGOS & P. CHAMBON. 1986. Human oestrogen receptor cDNA: sequence, expression, and homology to v-erb-A. Nature 320: 134-139.
13. KEAVENEY, M., J. KLUG & M. T. DAWSON. 1992. Evidence for a previously unidentified upstream exon in the human estrogen receptor gene. Mol. Endocrinol. 6: 111-115.
14. FUQUA, S. A. W., G. C. CHAMNESS & W. L. MCGUIRE. 1993. Estrogen receptor mutations in breast cancer. J. Cell. Biochem. 51: 135-139.
15. DOTZLAW, H., M. ALKHALAF & L. C. MURPHY. 1992. Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol. Endocrinol. 6: 773-785.
16. WANG, Y. & R. J. MIKSICEK. 1991. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol. 5: 1707-1715.
17. MCGUIRE, W. L., G. C. CHAMNESS & S. A. W. FUQUA. 1992. Abnormal estrogen receptor in clinical breast cancer. J. Steroid Biochem. Mol. Biol. 43: 243-247.
18. PFEFFER, U., E. FECAROTTA, L. CASTAGNETTA & G. VIDALI. 1993. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res. 53: 741-743.
19. KOEHORST, S. G., H. M. JACOBS, J. H. THUSSEN & M. A. BLANKENSTEIN. 1993. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 45: 227-233.
20. PFEFFER, U., E. FECAROTTA & G. VIDALI. 1995. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res. In press.
21. KOENIG, R. J., M. A. LAZAR, R. A. HODIN, G. A. BRENT, P. R. LARSEN, W. W. CHIN & D. D. MOORE. 1989. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337: 659-661.
22. MOALLI, P. A., S. PILLAY, N. L. KRETT & S. T. ROSEN. 1993. Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells. Cancer Res. 53: 3877-3879.
23. CASTLES, C. G., S. A. W. FUQUA, D. M. KLOTZ & S. M. HILL. 1993. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 53: 5934-5939.
24. KOEHORST, S. G. A., J. J. COX, G. H. DONKER, S. LOPES DA SILVA, J. P. H. BURBACH, J. H. H. THIJSSEN & M. A. BLANKENSTEIN. 1994. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol. Cell. Endocrinol. 101: 237-245.
25. FUQUA, S. A. W., S. D. FITZGERALD, G. C. CHAMNESS, A. K. TANDON, D. P. MCDONNELL, Z. NAWAZ, B. W. O'MALLEY & W. L. MCGUIRE. 1991. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51: 105-109.
26. FUQUA, S. A. W., S. D. FITZGERALD, C. ALLRED, R. M. ELLEDGE, R. M. NAFAR, D. P. MCDONNELL, B. W. O'MALLEY, G. L. GREENE & W. L. MCGUIRE. 1992. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 52: 483-486.
27. TZUKERMAN, M. T., A. ESTY, D. SANTISO-MERE, P. DANELIAN, M. G. PARKER, R. B. STEIN, J. W. PIKE & D. P. MCDONNELL. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8: 21-30.
28. BOCQUEL, M. T., V. KUMAR, C. STRICKER, P. CHAMBON & H. GRONEMEYER. 1989. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor- and cell-specific. Nucleic Acids Res. 17: 2581-2595.
29. THEULAZ, I., R. HIPSKIND, B. TEN HEGGELER-BORDIER, S. GREEN, V. KUMAR, P. CHAMBON & W. WAHLI. 1988. Expression of human estrogen receptor mutants in Xenopus oocytes: correlation between transcriptional activity and ability to form protein-DNA complexes. EMBO J. 7: 1653-1660.
30. BERRY, M., D. METZGER & P. CHAMBON. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9: 2811-2818.
31. SKIPPER, J. K., L. J. YOUING, J. M. BERGERON, M. T. TETZLAFF, C. T. OSBORN & D. CREWS. 1993. Identification of an isoform of the estrogen receptor messenger RNA lacking exon four and present in the brain. Proc. Natl. Acad. Sci. U.S.A. 90: 7172-7175.
32. CARRUBA, G., U. PFEFFER, E. FECAROTTA, D. A. COVIELLO, E. D'AMATO, M. LO CASTO, G. VIDALI & L. CASTAGNETTA. 1994. Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res. 54: 1190-1193.
33. ZHANG, Q. X., A. BORG & S. A. W. FUQUA. 1993. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res. 53: 5882-5884.
34. DAFFADA, A. A. I., S. R. D. JOHNSTON, J. NICHOLLS & M. DOWSETT. 1994. Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction. J. Mol. Endocrinol. 13: 265-273.
35. DAFFADA, A. A. I., S. R. D. JOHNSTON, I. E. SMITH, S. DETRE, N. KING & M. DOWSETT. 1995. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res. 55: 288-293.
36. AUCHUS, R. J. & S. A. W. FUQUA. 1994. Clinical syndromes of hormone receptor mutations: hormone resistance and independence. Semin. Cell Biol. 5: 127-136.
37. STRASSER-WOZAK, E. M. C., R. HATTMANNSTORFER, M. HÁLA, B. L. HARTMANN, M. FIEGL, S. GELEY & R. KOFLER. 1995. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res. 55: 348-353.
38. MIKSICEK, R. J., Y. LEI & Y. WANG. 1993. Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res. Treat. 26: 163-174.